StockData
Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc. (AVTX) stock

AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$7.76+0.06 (+0.78%)

Close on Nov 13, 2026Market cap $416.17MP/E –Yield –

Avalo Therapeutics statistics

64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 22, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$416.17M
$275.32M
Enterprise Value
-$46.63M
$144.91M
PB Ratio
0.95
2.01
P/TBV Ratio
0.98
2.22

Share statisticsIndustry

Shares Change (YoY)
199.7%
10.8%
Shares Change (QoQ)
1.93%
0.49%
Float
53M
49M
Shares Held by Insiders
0.71%
11.6%
Shares Held by Institutions
135.4%
56.4%

Short sellingIndustry

Short Interest
9M
–
Short Interest Change
-25.5%
-0.80%
Short % of Float
16.7%
8.98%
Short % of Shares Outstanding
16.6%
6.30%
Days to Cover
2.09
5.16

Stock price statisticsIndustry

52-Week High
$24.27
–
52-Week Low
$6.53
–
20-Day Moving Average
$7.97
–
50-Day Moving Average
$12.33
–
200-Day Moving Average
$15.63
–
Average True Range (14)
$0.86
–
Price Change (1 Week)
12.0%
-1.15%
Price Change (1 Month)
-35.4%
-4.86%
Price Change (3 Months)
-61.1%
-21.1%
Price Change (6 Months)
-56.3%
-20.7%
Price Change (YTD)
-57.3%
-23.6%
Price Change (1 Year)
-49.7%
-22.7%
Price Change (3 Years)
-67.3%
-29.5%
Price Change (5 Years)
-99.9%
-77.8%
Price Change (10 Years)
-99.9%
-65.4%
Average Volume (10 Days)
2M
–
Average Volume (20 Days)
3M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.66
0.70
Relative Strength Index (14)
38.3
43.4
Volatility (1 Year)
91.6%
80.1%
Beta (5 Years)
0.87
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-33.6%
-50.3%
Return on Assets (ROA)
-29.2%
-40.6%
Return on Capital Employed (ROCE)
-20.9%
-38.0%

Financial positionIndustry

Current Ratio
16.63
3.30
Quick Ratio
19.21
2.39

GrowthIndustry

Revenue Growth (3Y CAGR)
-85.2%
2.25%
Revenue Growth (5Y CAGR)
-61.2%
6.41%

EfficiencyIndustry

Profits Per Employee
-$3.85M
-$690.06K
Employee Count
23
75
WACC
9.44%
10.2%

Income statement (TTM)Industry

Operating Income
-$95.56M
-$21.40M
Pretax Income
-$88.49M
-$12.98M
Net Income
-$88.65M
-$22.39M
EBITDA
-$95.49M
-$17.04M
EPS (Diluted)
-$2.90
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$462.80M
$17.80M
Net Cash Per Share
$8.63
$0.80
Equity (Book Value)
$436.55M
$53.27M
Book Value Per Share
$8.14
$1.50
Tangible Book Value
$426.04M
$26.82M
Working Capital
$376.64M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
-$63.47M
-$12.35M

Dividends and yieldsIndustry

Earnings Yield
-21.3%
-22.0%

Taxes and interestIndustry

Income Tax
$167.00K
$73.00K

Scores and fair valueIndustry

Altman Z-Score
4.32
0.23
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodAVTXS&P 500DifferenceAVTX per yearS&P 500 per year
1 month-35.4%-3.0%−32.3 pts
3 months-60.1%-2.8%−57.3 pts
Year to date-57.3%+11.5%−68.8 pts
1 year-47.3%+13.5%−60.8 pts
3 years-64.4%+77.7%−142.1 pts-29.2%+21.1%
5 years-99.9%+72.6%−172.5 pts-74.0%+11.5%
10 years-99.9%+308.2%−408.1 pts-52.4%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

9M AVTX shares were sold short on Oct 30, 2026, down 25.5% from the previous report, or 16.73% of the shares available to trade. At recent volumes it would take 2.1 days to buy them back. Over the last 20 sessions, 32.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20268,910,655-25.5%4,261,9982.1
Oct 15, 202611,963,625+4.9%919,67613.0
Sep 30, 202611,405,304-11.8%1,296,4168.8
Sep 15, 202612,925,869+4.4%976,37613.2
Aug 31, 202612,387,012-5.4%816,59615.2
Aug 14, 202613,092,767+1.1%647,14320.2
Jul 31, 202612,950,314+2.1%900,45414.4
Jul 15, 202612,679,040+3.0%1,186,74210.7
Jun 30, 202612,307,967+66.0%2,887,4284.3
Jun 15, 20267,413,562+16.2%1,340,0305.5
May 29, 20266,382,270+2.1%1,464,0024.4
May 15, 20266,254,061+9.1%3,938,7111.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?